Dr. Levi’s clinical research and the implementation of automation in Pap test screening in the Yale cytology division has lead to improvements in the Pap test QA/QC program, cytotechnologist workload, laboratory efficiency, and the turn-around-time of Pap test results. Additionally, her clinical research and the implementation of concurrent molecular testing from liquid-based Pap tests has aided in outpatient gynecologic care and clinical management of infectious vaginitis/cervical disease and human papillomavirus-related cervical dysplasia. Building on her previous experience at a private sector pathology laboratory that studied prostate cancer biomarkers with image analysis, her research interests also include prostate cancer pathology and correlation with image analysis.
Uterine Cervical Dysplasia; Pathology; Prognosis; Prostate; Global Health; Cancer Vaccines; Human papillomavirus 16; Early Detection of Cancer; Human Papillomavirus DNA Tests; Atypical Squamous Cells of the Cervix; Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; Machine Learning; COVID-19; SARS-CoV-2; COVID-19 Vaccines; COVID-19 Testing
Cancer; Clinical Trials; Emerging Infectious Diseases; Global Health; Sexually-Transmitted Infections; Vaccines; Health Equity, Disparities, Social Determinants and Justice; Implementation Science